Notice: Prescription Drug List (PDL): Triamcinolone acetonide

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 17:27 (TU)
Créé le avril 17, 2026, 17:27 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-05-18 00:00:00
open_canada_keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "Acétonide de triamcinolone"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "Triamcinolone acetonide"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis : Liste des drogues sur ordonnance (LDO) : acétonide de triamcinolone
update_frequency as_needed